Clinical Trial Update: Safety and Antiviral Activity of a Monoclonal Hepatitis B Antibody (The SAMBA Study) [Phase 1]

View source ↗

Summary

Phase 1 study assessing safety and antiviral activity of a monoclonal antibody targeting Hepatitis B is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatitis B

Drugs mentioned

• HBV-specific monoclonal antibody (SAMBA Study) (HBV-specific monoclonal antibody)

Snippet

Sponsor: Aarhus University Hospital | Conditions: Hepatitis B | Phase 1 | Status: RECRUITING